Supplemental Oxygen for Airway Management
(OPTIMISE-2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the optimal oxygen flow rate for young patients undergoing tracheal intubation, a procedure to assist breathing. Researchers aim to determine if a significant difference exists between low-flow and high-flow oxygen during this procedure. The trial compares two groups: one using low-flow nasal supplemental oxygen and the other using high-flow nasal supplemental oxygen. It seeks newborns and infants up to 52 weeks old who require intubation for planned or semi-urgent surgeries. As an unphased trial, this study provides a unique opportunity for patients to contribute to important research that could enhance future medical procedures.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for airway management?
Research has shown that both low-flow and high-flow oxygen are generally safe during the insertion of a breathing tube. One study found that high-flow oxygen maintained better oxygen levels than low-flow oxygen in some situations. Despite this, low-flow oxygen remains widely used and is usually well-tolerated. Another study found that low-flow oxygen sometimes resulted in lower oxygen levels after tube insertion, but serious side effects were rare.
Overall, medical settings safely use both methods. While low-flow oxygen might not boost oxygen levels as effectively as high-flow oxygen, it remains a safe choice for many patients.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different approaches to delivering supplemental oxygen during tracheal intubation, which is crucial for maintaining patient safety. The intervention group uses a low-flow nasal supplemental oxygen method, providing 0.2 L/kg/min FiO2 1.0, which could offer a gentler alternative to high-flow systems. On the other hand, the control group uses high-flow nasal supplemental oxygen at 2 L/kg/min FiO2 1.0, a more common practice. This trial aims to assess whether the low-flow method is as effective as the high-flow approach, potentially leading to more tailored oxygen delivery strategies during airway management.
What evidence suggests that this trial's treatments could be effective for airway management?
Research has shown that high-flow nasal oxygen (HFNO) helps maintain better oxygen levels during tracheal intubation. In this trial, participants in the control group will receive high-flow nasal supplemental oxygen. Studies have linked this to higher minimum oxygen levels, indicating generally better oxygen levels for patients. Conversely, participants in the intervention group will receive low-flow nasal supplemental oxygen, which has been associated with lower oxygen levels in some cases. For example, one study found that after intubation, only 12.9% of patients using high-flow oxygen experienced low oxygen levels, compared to 57.1% of those using low-flow oxygen. This evidence suggests that high-flow oxygen may be more effective at maintaining stable oxygen levels during intubation.678910
Who Is on the Research Team?
Thomas Riva, MD
Principal Investigator
University of Bern
Are You a Good Fit for This Trial?
This trial is for neonates and infants up to 52 weeks postconceptual age who need oral or nasal tracheal intubation for various medical procedures. Legal guardians must consent. It's not suitable for those outside this age range or without guardian consent.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preparation and Induction
Eligible children are prepared for intubation according to local SOPs, including pre-oxygenation and administration of anesthesia and neuromuscular blocking agents.
Intubation Procedure
Tracheal intubation is performed with randomized low-flow or high-flow supplemental oxygen using the C-MAC video laryngoscope.
Follow-up
Participants are monitored for respiratory complications and other outcomes within the first 24 hours post-intubation.
What Are the Treatments Tested in This Trial?
Interventions
- High-flow nasal supplemental oxygen
- Laryngoscopy
- Low-flow nasal supplemental oxygen
- Tracheal Intubation
Trial Overview
The study compares high-flow versus low-flow supplemental oxygen during tracheal intubation using a C-MAC video laryngoscope in young patients. The goal is to find the best oxygen flow rate needed during this procedure.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
0.2 L/kg/min FiO2 1.0 low-flow nasal supplemental oxygen with conventional nasal cannula during tracheal intubation performed with the C-MAC videolaryngoscope (Karl Storz, Tuttlingen, Germany) with Miller-blade or Macintosh-blade size No. 0 or No. 1.
2 L/kg/min FiO2 1.0 high-flow nasal supplemental oxygen with the Optiflow (Fisher \& Paykel Healthcare, Auckland, New Zealand) during tracheal intubation performed with the C-MAC videolaryngoscope (Karl Storz, Tuttlingen, Germany) with Miller-blade or Macintosh-blade size No. 0 or No. 1.
Laryngoscopy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Airway management
- Endotracheal tube placement
- Anesthesia support
- Airway management
- Endotracheal tube placement
- Anesthesia support
- Airway management
- Endotracheal tube placement
- Anesthesia support
- Airway management
- Endotracheal tube placement
- Anesthesia support
- Airway management
- Endotracheal tube placement
- Anesthesia support
- Airway management
- Endotracheal tube placement
- Anesthesia support
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thomas Riva
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
Istituto Giannina Gaslini
Collaborator
Royal Perth Hospital
Collaborator
University Hospital, Geneva
Collaborator
Centre Hospitalier Universitaire Vaudois
Collaborator
Luzerner Kantonsspital
Collaborator
Charite University, Berlin, Germany
Collaborator
Gaslini Children's Hospital
Collaborator
The Hospital for Sick Children
Collaborator
Published Research Related to This Trial
Citations
Effectiveness of high-flow nasal cannula for tracheal ...
We found that the use of HFNC during tracheal intubation was potentially associated with a higher lowest SpO 2 during the procedure in comparison to ...
Efficacy of high-flow nasal oxygenation compared with ...
This randomised study shows that high-flow nasal oxygenation may be as effective as tracheal intubation in oxygenation during laryngeal microsurgery.
A propensity score-adjusted analysis of efficacy of high- ...
Our findings suggest that HFNO was associated with improved lowest oxygen saturation and a lower rate of multiple attempts during ATI.
4.
journals.lww.com
journals.lww.com/anesthesia-analgesia/fulltext/2025/11000/high_flow_nasal_oxygen_versus_mechanical.27.aspxHigh-Flow Nasal Oxygen versus Mechanical Ventilation... ...
Primary outcome was intraoperative respiratory support success rate, which was defined as peripheral oxygen saturation greater than 94% and transcutaneous ...
Nasal High-Flow Therapy during Neonatal Endotracheal ...
We performed a randomized, controlled trial to compare nasal high-flow therapy with standard care (no nasal high-flow therapy or supplemental ...
Randomized controlled trial to assess the effectiveness of ...
This randomized controlled trial evaluated whether apnoeic oxygenation using HFNC or LFNC with head elevation improves oxygenation and intubation outcomes
Evidence-based Emergency Tracheal Intubation
Hypotension occurs during 25–40% of emergency tracheal intubations and may be associated with an increased risk of cardiac arrest and death (2, ...
Study Details | NCT05967507 | Laryngoscopy for Neonatal ...
This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, ...
Effect of Noninvasive Respiratory Strategies on Intubation ...
An initial strategy of CPAP significantly reduced the risk of tracheal intubation or mortality compared with conventional oxygen therapy.
143 A Randomized Control Trial to Assess Effectiveness ...
Post intubation non-invasive oxygen saturation < 92% was seen in 4 [12.9%] in high flow, 16 [57.1%] in low flow and 7 [20%] in standard arm with a p-value of < ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.